Call us on 01942 271 746

Seneca Partners £20m investment in the UK’s brightest SMEs

With continuing demand from investors for access to exciting corporate investment opportunities, the investment management and corporate advisory business, Seneca Partners, has started 2015 with significant EIS equity funding available and the expectation of investing more than £20m into the UK’s most exciting SMEs in the coming year. Seneca Partners, the North West based investment manager, [...]

View Full News Article

RedX £20m IPO to help discover ‘first new class of antibiotics in a generation.’

Seneca EIS portfolio company RedX Pharma has confirmed its plans to raise £20m by listing on the London Stock Exchange. The business employs 50 staff at a base in the former AstraZeneca site, at Alderley Park, Cheshire. See the article in full at

View Full News Article

Premaitha Health CEO on ‘exciting new market’

Dr Stephen Little, the chief executive of Seneca portfolio company Premaitha Health (LON:NIPT), tells Proactive Investors why the prenatal testing market is so exciting. See video here  

View Full News Article

Seneca supports Collagen Solutions acquisition of Southern Lights

Seneca has backed the recent acquisition of Southern Lights by Collagen Solutions, an AIM-listed company specializing in medical grade collagen components. The acquisition will provide Collagen with access to bovine sourced collagen from New Zealand which is a negligible BSE risk country. This acquisition will complement the existing supply chain and improve end user offering. [...]

View Full News Article

Seneca Partners injects financial fuel into car retailer

North West-based firm takes £1m stake in pioneering multichannel car retailer Rockar Auto business offers a seamless online way to buy and own a car – combined with its first physical showroom at the Bluewater shopping centre The investment management and corporate advisory business, Seneca Partners, has bought a £1million stake in the multichannel car retailer [...]

View Full News Article

OptiBiotix Health plc sign up human studies with Reading University

Seneca investee company, OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has signed an agreement with the University of Reading for the commencement of human studies on its first product, a capsular food supplement to reduce cholesterol. This is in addition to the successful early [...]

View Full News Article

News Categories

Upcoming Events

There are no upcoming events at this time.


Subscribe to RSS Feed

To stay up to date with all the latest news enter your email below - get the latest updates straight to your inbox.

subscribe to RSS feed